Structural basis of valmerins as dual inhibitors of GSK3β/CDK5.
about
Designing of dual inhibitors for GSK-3β and CDK5: Virtual screening and in vitro biological activities studyThe Role of Cdk5 in Alzheimer's Disease.Computationally unraveling how ceritinib overcomes drug-resistance mutations in ALK-rearranged lung cancer.Recent Developments and Applications of the MMPBSA Method.Atomistic insights into the lung cancer-associated L755P mutation in HER2 resistance to lapatinib: a molecular dynamics study.Underlying mechanisms of cyclic peptide inhibitors interrupting the interaction of CK2α/CK2β: comparative molecular dynamics simulation studies.
P2860
Structural basis of valmerins as dual inhibitors of GSK3β/CDK5.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Structural basis of valmerins as dual inhibitors of GSK3β/CDK5.
@en
Structural basis of valmerins as dual inhibitors of GSK3β/CDK5.
@nl
type
label
Structural basis of valmerins as dual inhibitors of GSK3β/CDK5.
@en
Structural basis of valmerins as dual inhibitors of GSK3β/CDK5.
@nl
prefLabel
Structural basis of valmerins as dual inhibitors of GSK3β/CDK5.
@en
Structural basis of valmerins as dual inhibitors of GSK3β/CDK5.
@nl
P2093
P2860
P1476
Structural basis of valmerins as dual inhibitors of GSK3β/CDK5.
@en
P2093
Houling Zhao
Shaoyong Lu
Weisong Li
Xiaolong Li
Xiaowei Wang
Zibin Tian
P2860
P2888
P356
10.1007/S00894-014-2407-1
P577
2014-08-21T00:00:00Z